PFJR versus TKR : Indications and Outcomes

Introduction Symposium 2 minutes Paul Monk, DPhil (Oxon), FRCS, NEW ZEALAND
PFJ Arthritis - Not All Patients are Made Equally Symposium 9 minutes Elizabeth A. Arendt, MD, UNITED STATES
Design Considerations for the PFJ in Arthroplasty Symposium 6 minutes Paul Monk, DPhil (Oxon), FRCS, NEW ZEALAND
Arthroplasty Technique/Philosophies from the PFJ's Perspective: Pearls and Pitfalls Symposium 7 minutes David H. Dejour, MD, FRANCE
Discussion Symposium 30 minutes Elizabeth A. Arendt, MD, UNITED STATES David H. Dejour, MD, FRANCE Pieter J. Erasmus, MBChB, MMed, FCS(Orth), SOUTH AFRICA Paul Monk, DPhil (Oxon), FRCS, NEW ZEALAND